Affinity Asset Advisors »

Cogent Biosciences shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Cogent Biosciences shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Cogent Biosciences

Tip: Access up to 7 years of quarterly data

All positions including Cogent Biosciences held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cogent Biosciences by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2026-03-31 $8.6M 7.0M 1.23
2025-12-31 $1.2M 1.0M 1.18

More positions owned by Affinity Asset Advisors

State Str Spdr S&p 500 Etf T Tr Unit Put Option (SPY)
Apogee Therapeutics (APGE)
Xenon Pharmaceuticals (XENE)
Erasca (ERAS)
Insmed Com Par $.01 (INSM)
Roivant Sciences SHS (ROIV)
Spyre Therapeutics Com New (SYRE)
Centessa Pharmaceuticals Sponsored Ads
Praxis Precision Medicines I Com New (PRAX)
Anaptysbio Inc Common (ANAB)
Alkermes SHS (ALKS)
Cytokinetics Com New (CYTK)
Abivax Sa Sponsored Ads (ABVX)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Arcellx Common Stock (ACLX)

View all positions for Affinity Asset Advisors

Top funds holding Cogent Biosciences

Linden Advisors
Wolverine Asset Management
Jump Financial
Calamos Advisors
Oaktree Capital Management
Lord, Abbett & Co
Affinity Asset Advisors
Ameriprise Financial
Wellesley Investment Advisors
Advent Capital Management
SSI Investment Management
Polar Capital Holdings
Henderson Group
Leucadia National Corporation
Millennium Management

View all funds holding Cogent Biosciences